Epithelial–mesenchymal transition to mitigate age-related progression in lung cancer
Ageing Research Reviews · 2024-12 · 102 · 102576
DOI: 10.1016/j.arr.2024.102576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024-12. Verfasst von Riya Thapa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Lung Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 320 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Epithelial-Mesenchymal Transition (EMT) is a fundamental biological process involved in embryonic development, wound healing, and cancer progression. In lung cancer, EMT is a key regulator of invasion and metastasis, significantly contributing to the fatal progression of the disease. Age-related factors such as cellular senescence, chronic inflammation, and epigenetic alterations exacerbate EMT, accelerating lung cancer development in the elderly. This review describes the complex mechanism among EMT and age-related pathways, highlighting key regulators such as TGF-β, WNT/β-catenin, NOTCH, and Hedgehog signalling. We also discuss the mechanisms by which oxidative stress, mediated through pathways involving NRF2 and ROS, telomere attrition, regulated by telomerase activity and shelterin complex, and immune system dysregulation, driven by alterations in cytokine profiles and immune cell senescence, upregulate or downregulate EMT induction. Additionally, we highlighted pathways of transcription such as SNAIL, TWIST, ZEB, SIRT1, TP53, NF-κB, and miRNAs regulating these processes. Understanding these mechanisms, we highlight potential therapeutic interventions targeting these critical molecules and pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
- Chameli Devi Institute of Pharmacy, Department of Pharmacology, Indore, Madhya Pradesh, India.
- Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India. Electronic address: gauravpharma25@gmail.com.
- Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
- Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney…
Förderung
- Indian Council of Medical Research
Zitieren
APA
Thapa, R., Gupta, S., Gupta, G., Bhat, A. A., Smriti, Singla, M., Ali, H., Singh, S. K., Dua, K., & Kashyap, M. K. (2024). Epithelial–mesenchymal transition to mitigate age-related progression in lung cancer. Ageing Research Reviews, 102, 102576. https://doi.org/10.1016/j.arr.2024.102576
Vancouver
Thapa R, Gupta S, Gupta G, Bhat AA, Smriti, Singla M, et al. Epithelial–mesenchymal transition to mitigate age-related progression in lung cancer. Ageing Research Reviews. 2024;102:102576. doi:10.1016/j.arr.2024.102576
BibTeX
@article{Thapa2024,
author = {Thapa, Riya and Gupta, Saurabh and Gupta, Gaurav and Bhat, Asif Ahmad and Smriti and Singla, Madhav and Ali, Haider and Singh, Sachin Kumar and Dua, Kamal and Kashyap, Manoj Kumar},
title = {Epithelial–mesenchymal transition to mitigate age-related progression in lung cancer},
journal = {Ageing Research Reviews},
year = {2024},
volume = {102},
pages = {102576},
doi = {10.1016/j.arr.2024.102576}
}
EUVIMED